Abstract
Purpose In this study, we investigated the performance of deep learning (DL) models to differentiate between normal and glaucomatous visual fields (VFs) and classify glaucoma from early to the advanced stage to observe if the DL model can stage glaucoma as Mills criteria using only the pattern deviation (PD) plots. The DL model results were compared with a machine learning (ML) classifier trained on conventional VF parameters.
Methods A total of 265 PD plots and 265 numerical datasets of Humphrey 24-2 VF images were collected from 119 normal and 146 glaucomatous eyes to train the DL models to classify the images into four groups: normal, early glaucoma, moderate glaucoma, and advanced glaucoma. The two popular pre-trained DL models: ResNet18 and VGG16, were used to train the PD images using five-fold cross-validation (CV) and observed the performance using balanced, pre-augmented data (n= 476 images), imbalanced original data (n=265) and feature extraction. The trained images were further investigated using the Grad-CAM visualization technique. Moreover, four ML models were trained from the global indices: mean deviation (MD), pattern standard deviation (PSD) and visual field index (VFI), using five-fold CV to compare the classification performance with the DL model’s result.
Results The DL model, ResNet18 trained from balanced, pre-augmented PD images, achieved high accuracy in classifying the groups with an overall F1-score: 96.8%, precision: 97.0%, recall: 96.9%, and specificity: 99.0%. The highest F1 score was 87.8% for ResNet18 with the original dataset and 88.7% for VGG16 with feature extraction. The DL models successfully localized the affected VF loss in PD plots. Among the ML models, the random forest (RF) classifier performed best with an F1 score of 96%.
Conclusion The DL model trained from PD plots was promising in differentiating normal and glaucomatous groups and performed similarly to conventional global indices. Hence, the evidence-based DL model trained from PD images demonstrated that the DL model could stage glaucoma using only PD plots like Mills criteria. This automated DL model will assist clinicians in precision glaucoma detection and progression management during extensive glaucoma screening.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the University of New South Wales, Sydney gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
